5 reports

It offers TG## and various candidates for chronic hepatitis B and tuberculosis.

  • Ear, Nose, And Throat Medicine
  • Sexually Transmitted Disease
  • Vaccine
  • United States
  • Advaxis, Inc.

Tuberculosis Completed Phase I Interventional golotimod SciClone Pharmaceuticals, Inc. ## Dec 2005 ## Sep 2006 Signal Transducer And Activator Of Transcription ## (Acute Phase Response Factor or DNA Binding Protein APRF or STAT##) Inhibitor Signal Transducer And Activator Of Transcription ## (

  • Ear, Nose, And Throat Medicine
  • Hospital
  • World
  • Product Initiative
  • Amgen Inc.
  • VACCINE FOR AUTOIMMUNE DISEASE, CARDIOVASCULAR DISEASE, IMMUNOLOGY, INFECTIOUS DISEASE AND ONCOLOGY - DRUG PROFILE
  • SMALL MOLECULES FOR HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - DRUG PROFILE
  • Ear, Nose, And Throat Medicine
  • Lung Cancer
  • United States
  • Company
  • Product Initiative
  • SMALL MOLECULES FOR HEAD AND NECK CANCER SQUAMOUS CELL CARCINOMA - DRUG PROFILE

The funds will allow Molplex to extend its automated drug discovery technology platform and advance its current pipeline of internal and partnered discovery projects, including the development of new medicines for Dengue Virus, new antibiotics for resistant bacteria, persistent

  • Cancer
  • Ear, Nose, And Throat Medicine
  • United States
  • Company
  • Product Initiative

The company has preclinical data in a range of animal models within cancer and infectious diseases including vaccines against human papilloma virus induced cancer, multiple myeloma, influenza, melanoma, prostate cancer, B cell lymphoma, herpes simplex virus ##, HIV and tuberculosis.

  • Ear, Nose, And Throat Medicine
  • Genitourinary System Disease
  • United States
  • Product Initiative
  • CEL-SCI Corporation